Noradrenergic Regulation in the BNST
BNST 中的去甲肾上腺素能调节
基本信息
- 批准号:9920688
- 负责人:
- 金额:$ 35.27万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-07-01 至 2022-04-30
- 项目状态:已结题
- 来源:
- 关键词:Adrenergic AgentsAdrenergic AgonistsAdrenergic AntagonistsAdrenergic ReceptorAmygdaloid structureArousalAutomobile DrivingAutoreceptorsBehaviorBrainCatecholaminesCell NucleusCellsClinicalCocaineCorticotropin-Releasing HormoneCorticotropin-Releasing Hormone ReceptorsDataEffectivenessElectrophysiology (science)FOS geneFinancial HardshipFundingGlutamatesGuanfacineHealthHumanHypothalamic structureInfusion proceduresLeadLigandsLiteratureLocationMediatingModelingMotivationMusNeuronsNorepinephrineOutcomePainPathway interactionsPharmaceutical PreparationsPlayPopulationProcessPropranololReceptor ActivationReceptor SignalingRegulationRelapseReporterRewardsRodentRoleSignal TransductionSliceSocietiesSourceStressStructure of terminal stria nuclei of preoptic regionSynaptic TransmissionSystemTestingTherapeuticViraladdictionbehavioral responsebeta-adrenergic receptorbrain circuitrycell typecocaine exposureconditioned place preferencecravingdrug of abuseenhancing factorexperimental studyhyperpolarization-activated cation channelimprovedimproved outcomenew therapeutic targetnoradrenergicnoveloptogeneticspostsynapticprophylacticreceptorrecruitresponsesuccesstargeted treatmenttherapeutic candidatetherapeutic developmenttransmission processtreatment strategywithdrawal-induced anxiety
项目摘要
Project Summary
Addiction is a tremendous health and financial burden on our society. A growing literature indicates that
norepinephrine in the brain plays a key role in stress-reward interactions that may mediate key behavioral
responses to drugs of abuse. A previously unappreciated group of noradrenergic neurons in the field of
addiction, cells that project through the ventral noradrenergic bundle (VNAB), are thought to supply the key
norepinephrine. The primary target of the VNAB in the brain is a group of nuclei referred to as the extended
amygdala. In the previous funding periods, we identified actions of each of the major classes of noradrenergic
receptors on excitatory synaptic transmission in the bed nucleus of the stria terminalis, a major component of
the extended amygdala. Moreover, we identified a novel mechanism whereby the noradrenergic system
interacts with the corticotropin releasing factor receptor signaling system to drive recruitment of specific
populations of VTA projecting neurons. We also identified novel actions of alpha2-adrenergic receptors in
regulation of excitatory drive into the BNST.
Adrenergic ligands have been identified as potential prophylactic therapeutic candidates in treating
addiction. While results in human studies have been encouraging, their overall success in improving outcomes
has been modest. We propose that this is in part due to the many disparate actions that the receptors
regulated by these ligands regulate, and that if we could develop a more specific understanding of the
regulated actions that were key to drug-seeking, we could fine tune treatment strategies to increase
effectiveness. Here, we propose experiments to delineate specific pathways through which catecholamine-
CRF signaling interactions regulate stress-induced cocaine seeking, and alpha2-adrenergic receptor-induced
suppression of stress-induced reinstatement.
项目摘要
成瘾是我们社会的巨大健康和经济负担。越来越多的文献表明
大脑中的去甲肾上腺素在应力奖励相互作用中起关键作用,这可能介导关键行为
对滥用药物的反应。以前未经批准的甲肾上腺素能神经元的群体
成瘾,通过腹侧去甲肾上腺素能束(VNAB)投射的细胞被认为提供了钥匙
去甲肾上腺素。大脑中VNAB的主要目标是一组核,称为扩展
杏仁核。在前面的资金期间,我们确定了甲肾上腺素能的每个主要类别的行动
受体的受体在质子末端的床核中的兴奋性突触传播,这是一个主要组成部分
扩展的杏仁核。此外,我们确定了一种新型机制,甲肾上腺素能系统
与皮质激素释放因子受体信号系统相互作用,以推动特定的募集
VTA投影神经元的种群。我们还确定了α2-肾上腺素受体的新作用
调节兴奋性驱动器进入BNST。
肾上腺素能的配体已被确定为治疗中潜在的预防治疗候选者
瘾。尽管人类研究的结果令人鼓舞,但它们在改善结果方面的总体成功
谦虚。我们建议这部分是由于受体的许多不同作用
由这些配体调节的调节,如果我们能够对
受到寻求毒品关键的管制行动,我们可以微调治疗策略以增加
效力。在这里,我们提出了实验,以描绘儿茶酚胺 -
CRF信号传导相互作用调节应力诱导的可卡因寻求,而α2-肾上腺素受体诱导的
抑制应力诱导的恢复原状。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DANNY G WINDER其他文献
DANNY G WINDER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DANNY G WINDER', 18)}}的其他基金
BNST GluN2B and CRF signaling in the antidepressant actions of ketamine
BNST GluN2B 和 CRF 信号在氯胺酮抗抑郁作用中的作用
- 批准号:
8717064 - 财政年份:2014
- 资助金额:
$ 35.27万 - 项目类别:
Alcohol action on extended amygdala glutamate synapses
酒精对延长杏仁核谷氨酸突触的作用
- 批准号:
10515868 - 财政年份:2010
- 资助金额:
$ 35.27万 - 项目类别:
Alcohol action on extended amygdala glutamate synapses
酒精对延长杏仁核谷氨酸突触的作用
- 批准号:
10670471 - 财政年份:2010
- 资助金额:
$ 35.27万 - 项目类别:
Alcohol action on extended amygdala glutamate synapses
酒精对延长杏仁核谷氨酸突触的作用
- 批准号:
8658782 - 财政年份:2010
- 资助金额:
$ 35.27万 - 项目类别:
相似国自然基金
肾上腺素能受体激动剂引起睑板腺功能障碍发病的机制研究
- 批准号:82371024
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
水体中β2-肾上腺素受体激动剂(PPCPs)间接光降解机理的量子化学与实验研究
- 批准号:22306084
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
α2A/2B-肾上腺素受体偏向激活Gαs的激动剂作用位点及其功能相关性研究
- 批准号:82273909
- 批准年份:2022
- 资助金额:52.00 万元
- 项目类别:面上项目
α2A/2B-肾上腺素受体偏向激活Gαs的激动剂作用位点及其功能相关性研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
β3肾上腺素受体激动剂对小鼠肩袖延迟修复后肌肉脂肪浸润的治疗作用及机制研究
- 批准号:81902245
- 批准年份:2019
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
相似海外基金
The role of VSNL1 in human heart rate regulation
VSNL1在人体心率调节中的作用
- 批准号:
10750747 - 财政年份:2023
- 资助金额:
$ 35.27万 - 项目类别:
Roles of Rad and other CaV1.2 neighboring proteins in regulating cardiac function in health and disease
Rad 和其他 CaV1.2 邻近蛋白在健康和疾病中调节心脏功能中的作用
- 批准号:
10628915 - 财政年份:2023
- 资助金额:
$ 35.27万 - 项目类别:
Development of microencapsulated PI301 targeting lung GABAergic signaling
开发针对肺 GABA 信号传导的微囊 PI301
- 批准号:
10478543 - 财政年份:2022
- 资助金额:
$ 35.27万 - 项目类别:
Discovering new therapies to promote myelin repair
发现促进髓磷脂修复的新疗法
- 批准号:
10314338 - 财政年份:2021
- 资助金额:
$ 35.27万 - 项目类别:
The impact of chronic stress on radiation induced cell death and the anti-tumor immune response
慢性应激对辐射诱导的细胞死亡和抗肿瘤免疫反应的影响
- 批准号:
10313613 - 财政年份:2021
- 资助金额:
$ 35.27万 - 项目类别: